Clinical predictors of asthmatics in identifying subgroup requiring long-term tiotropium add-on therapy: a real-world study

BACKGROUND: According to several phase III studies, tiotropium [a long-acting muscarinic antagonist (LAMA)] is a well-tolerated add-on therapy to inhaled corticosteroids (ICS) for asthmatics with or without the addition of long-acting beta2-agonists (LABAs). However, real-world studies based on clin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Thorac Dis
Egile Nagusiak: Cheng, Wen-Chien, Liao, Wei-Chih, Wu, Biing-Ru, Chen, Chih-Yu, Shen, Meng-Fang, Chen, Wei-Chun, Hsia, Te-Chun, Tu, Chih-Yen, Chen, Chia-Hung, Hsu, Wu-Huei
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790467/
https://ncbi.nlm.nih.gov/pubmed/31656651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.09.22
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak